Molecular Imaging of Cardiac Metabolism, Innervation, and Conduction

Kaat Luyten; Matthias Schoenberger

doi:10.33590/emjcardiol/10313817

12 Oct 2017

Molecular Imaging of Cardiac Metabolism, Innervation, and Conduction

Cardiac diseases have complex molecular origins. However, current clinical diagnostic tools are often inadequate to uncover specific molecular components…

1 Mins

12 Oct 2017

Apolipoprotein CIII and Triglycerides in the Necrotic Core Contribute to Plaque Vulnerability in Patients with Stable Coronary Disease

Apolipoprotein CIII (Apo CIII) not only regulates triglyceride (TG) metabolism but also contributes to atherosclerotic formation…

10 Mins

12 Oct 2017

Neutrophils in Acute Coronary Syndrome

Acute coronary syndrome (ACS) encompasses a spectrum of clinical disorders of myocardial ischaemia or infarction, with atherosclerosis leading to…

1 Mins

12 Oct 2017

Left Atrial Parameter to Differentiate Between Physiological or Pathological Process of the left Ventricle

Athletes with pathological hearts are at risk of sudden death through cardiac events. Athletes undergo physiological changes to the heart…

7 Mins

12 Oct 2017

Ectopic Beats: How Many Count?

Premature atrial and ventricular contractions, or ectopic beats, are frequently detected on routine electrocardiogram monitoring.

1 Mins

12 Oct 2017

P-Wave Dispersion and its Association with Hypertension

Hypertension and obesity in adults have been associated with increased P-wave dispersion (PwD). This is postulated due to the correlation of hypertension…

9 Mins

12 Oct 2017

Arrhythmogenic Cardiomyopathy: Genetic Pathology, Inflammatory Syndrome, or both?

Arrhythmogenic cardiomyopathy (ACM) affects mainly young athletes <35 years old and has a potential risk of malignant arrhythmias and sudden death.

9 Mins

12 Oct 2017

Cardiac Cachexia Syndrome

This review gathers evidence to enable recognition of cardiac cachexia and improve identification of patients with terminal heart failure.

October 2017

EMJ Cardiology 5.1 2017

Inside, you will find copious amounts of exciting, new research, including some fantastic highlights from this year’s ESC…

10 Oct 2017

RedHill Biopharma Announces Positive Top-Line Results from Phase II Study of BEKINDA® in Patients with Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)

Tel-Aviv, Israel/Raleigh, NC, USA, 03 October, 2017 – RedHill Biopharma Ltd. (NASDAQ: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“Red Hill” or the “Company”)…

Molecular Imaging of Cardiac Metabolism, Innervation, and Conduction

Apolipoprotein CIII and Triglycerides in the Necrotic Core Contribute to Plaque Vulnerability in Patients with Stable Coronary Disease

Neutrophils in Acute Coronary Syndrome

Left Atrial Parameter to Differentiate Between Physiological or Pathological Process of the left Ventricle

Ectopic Beats: How Many Count?

P-Wave Dispersion and its Association with Hypertension

Arrhythmogenic Cardiomyopathy: Genetic Pathology, Inflammatory Syndrome, or both?

Cardiac Cachexia Syndrome

EMJ Cardiology 5.1 2017

RedHill Biopharma Announces Positive Top-Line Results from Phase II Study of BEKINDA® in Patients with Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)

Therapy Area

About Us